Quince Therapeutics, Inc. (NASDAQ:QNCX) Short Interest Down 42.9% in May
Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) was the recipient of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 605,000 shares, a decline of 42.9% from the April 30th total of 1,060,000 shares. Based on an average daily volume of 278,700 shares, […]
